Point-of-care microfluidic devices for pathogen detection
B Nasseri, N Soleimani, N Rabiee, A Kalbasi… - Biosensors and …, 2018 - Elsevier
The rapid diagnosis of pathogens is crucial in the early stages of treatment of diseases
where the choice of the correct drug can be critical. Although conventional cell culture-based …
where the choice of the correct drug can be critical. Although conventional cell culture-based …
Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma
A Arzumanyan, HM Reis, MA Feitelson - Nature Reviews Cancer, 2013 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …
[PDF][PDF] Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma
(HCC). Antiviral agents are thought to reduce HCC development, but agents such as …
(HCC). Antiviral agents are thought to reduce HCC development, but agents such as …
[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Background Therapy for chronic hepatitis B reduces the risk of progressing to hepatocellular
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
carcinoma (HCC); however, there is no suitable and accurate means to assess risk. This …
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy - Journal of viral hepatitis, 2004 - Wiley Online Library
Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people
infected worldwide, and 350 million suffering from chronic HBV infection. The 10th leading …
infected worldwide, and 350 million suffering from chronic HBV infection. The 10th leading …
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
ContextSerum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy
of antiviral treatment in individuals with chronic hepatitis B. ObjectiveTo evaluate the …
of antiviral treatment in individuals with chronic hepatitis B. ObjectiveTo evaluate the …
[PDF][PDF] Chronic hepatitis B
ASF Lok, BJ McMahon - Hepatology, 2007 - Wiley Online Library
These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …
the recognition, diagnosis, and management of patients chronically infected with the …
[HTML][HTML] Green synthesis, characterization and uses of palladium/platinum nanoparticles
KS Siddiqi, A Husen - Nanoscale research letters, 2016 - Springer
Biogenic synthesis of palladium (Pd) and platinum (Pt) nanoparticles from plants and
microbes has captured the attention of many researchers because it is economical …
microbes has captured the attention of many researchers because it is economical …
Hepatitis B virus infection
JL Dienstag - New England Journal of Medicine, 2008 - Mass Medical Soc
More effective and less resistance-prone antiviral agents are now available to treat hepatitis
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and …
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and …